In ovarian cancer, the upregulation of MUC16 activates the PI3K/Akt signaling pathway and promotes the expression of mesenchymal markers, such as N-cadherin, vimentin, and Snail, leading to increased proliferation, invasion, and metastasis [142]. Here, MUC16 is linked to ovarian cancer.